MedTech News
.................... by Andrew Celentano
Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes
Fentanyl Urine Visual Test is available through Labcorp Point of Care, previously known as MEDTOX Diagnostics
Robust flu protection may rely on B cells that are long-lived residents in the lungs
By identifying the molecular mechanisms that control BRM cell formation, the new study provides a clearer paradigm for understanding how long-term immunity is established in the respiratory tract.
Novel diabetic wound treatment turns cells into manufacturers
Zhao is part of a team working on a potential solution: a novel wound dressing that uses materials created by human cells—without including the cells themselves.
Brain-on-a-chip reveals how Parkinson’s proteins weaken the brain’s vascular barrier
New research from Binghamton University and Drexel University looks at a different, lesser-studied issue that also hurts patients and their quality of life: how Parkinson’s affects the human vascular system.
3D-printed brain sensors may unlock personalized neural monitoring
Soft electrodes designed to perfectly match a person’s brain surface may help advance neural interfaces for neurodegenerative disease monitoring and treatment, according to a new study led by Penn State researchers.
Skin-deep microneedle sensor tracks drug clearance and reveals early kidney and liver dysfunction
A UCLA-led research team has now developed a microneedle sensor platform designed to address that problem through continuous, minimally invasive monitoring in skin.
Growing liver tissue directly in the body could ease donor organ shortage
We asked if it would be possible to first implant a small-scale liver construct and then drive it to expand in the body following its engraftment.
Bracco Receives Health Canada Approval for VUEWAY® injection (gadopiclenol), Advancing Lower-Dose MRI Contrast Imaging
MONTREAL, April 17, 2026 /PRNewswire/ — Bracco Imaging, a global leader in diagnostic imaging, today announced that Health Canada approved VUEWAY® injection (gadopiclenol), a macrocyclic gadolinium-based contrast agent (GBCA), for use in contrast-enhanced magnetic resonance imaging (CE-MRI).